"
COVID-19 Research Working Group

Leading Coronavirus Research

News

Panel Cuts Through COVID-19 Confusion

May 19, 2020

UC Davis leaders and researchers gathered virtually May 14 to answer the public’s questions about COVID-19, ranging from the safety of homemade masks to whether children or pets could transmit the virus.

Distinguished Professor Walter Leal brought the panel together for his second COVID-19 Public Awareness Symposium. It featured straight talk from experts about many areas that have been shrouded in confusion and conflicting information.

UC Davis LIVE: Treating COVID-19

May 19, 2020

In the second edition of UC Davis LIVE: COVID-19, two UC Davis clinicians will talk about and take questions on the new treatments for COVID-19 being tested at UC Davis Health and other hospitals, including the experimental antiviral drug remdesivir — used to treat UC Davis’ first patient of the pandemic in March — and using plasma from people who have recovered from the novel coronavirus to treat patients.

National Science Foundation Grant to Help UC Davis Researchers Track Evolution of Novel Coronavirus

May 13, 2020

As the disease COVID-19 spreads across the planet, scientists continue to combat the novel coronavirus (SARS-Cov-2) on all fronts. But viruses are fickle, mutating to ensure their survival as they hop hosts. Genomic mutations and natural selection could reduce the effectiveness of a potential vaccine for the novel coronavirus, and different sequence variations and strains of the virus are continuously being reported in databases like GISAID.

Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?

May 12, 2020
UC Davis scientists provide senicapoc for clinical trial in Denmark

(SACRAMENTO) — Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.

UC Davis Health researchers provided one of those repurposed drugs, senicapoc, to launch a clinical trial at Aarhus University in Denmark. The study will assess whether the drug can mitigate lung damage in patients with COVID-19.

COVID-19 ‘Live’ Series Debuts May 7

May 05, 2020

‘Deans Discuss’ Podcast Launches Later in Month

By Andy Fell on May 5, 2020 in University  

UC Davis is launching two new series that take a deep dive into how our researchers are meeting the challenge of COVID-19. They will explore how UC Davis scientists, clinicians, engineers and others, often working across disciplines, are turning their knowledge to tackle COVID-19, from its origin to our communities and hospitals.